European Network for the Study of Adrenal Tumours Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01371201
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

ENSAT-CANCER European Network for the Study of Adrenal Tumours